Biogen Inc (NASDAQ: BIIB)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 12/23/2022
Closing price: 279.16
Support price level: | $267.07 |
Resistance price level: | $293.91 |
Relative strength index (14-day RSI) | 31.1 |
Beta | 0.55 |
- Volatility is forecast to fall over the next month.
- BIIB is above its 200-day moving average, providing a measure of support for long positions.
Low | High | Price as % of Range |
$187.54 | $306.72 | 80.9% |
200 day | 50 day | 20 day | 10 day |
$230.32 | $286.91 | $289.89 | $285.78 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
46.5% | 41.3% | 43.4% | 48.0% |
- 11.8% in the next week.
- 27.2% in the next month.
- 91.4% in the next year.
Company news for Biogen Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks